MABPAT_dataset
Data license: CC BY 4.0 · Data source: Novel dataset reveals growing prominence of deep-sea life for marine bioprospecting · About: About MABPAT
| Patent_application_number | Applicant_name | Year_of_application | Patent_system |
|---|---|---|---|
| EP1088891A1 | ROCHE DIAGNOSTICS | 2001 | EPO |
| EP1094069A1 | AKZO NOBEL N.V. (NL) | 2001 | EPO |
| JP2001011093A | UNITED STATES OF AMERICA | 2001 | JPO |
| JP2001011097A | FUJIREBIO INC | 2001 | JPO |
| JP2001069983A | UNITIKA LTD | 2001 | JPO |
| JP2001078786A | BASF | 2001 | JPO |
| JP2001078791A | AIST | 2001 | JPO |
| JP2001097884A | SABURO HARA,NATIONAL RESEARCH INSTITUTE OF AQUACULTURE | 2001 | JPO |
| JP2001169780A | AIST | 2001 | JPO |
| JP2001169793A | THE JOHNSON & JOHNSON | 2001 | JPO |
| JP2001211888A | AKZO NOBEL NV | 2001 | JPO |
| JP2001245677A | SRL INC,MARINE BIOTECHNOLOGY INST | 2001 | JPO |
| JP2001299348A | AIST | 2001 | JPO |
| JP2001321180A | TOSOH CORPORATION | 2001 | JPO |
| JP2001505435A | BARENTIS INC,BAYLOR COLLEGE OF MEDICINE | 2001 | JPO |
| JP2001506588A | MERCK | 2001 | JPO |
| JP2001507561A | GSK PLC | 2001 | JPO |
| JP2001510983A | BASF | 2001 | JPO |
| JP2001512678A | BASF | 2001 | JPO |
| JP2001512974A | REGENERON PHARMA | 2001 | JPO |
| JP2001518793A | PFIZER | 2001 | JPO |
| JP2001519142A | AMGEN | 2001 | JPO |
| JP2001519666A | PFIZER | 2001 | JPO |
| JP2001519667A | PFIZER | 2001 | JPO |
| JP2001526526A | HOLOGIC INC | 2001 | JPO |
| JP2001527389A | ROCHE DIAGNOSTICS | 2001 | JPO |
| JP2001527390A | CIBLEX CORP | 2001 | JPO |
| US6331401B1 | LUNDBECK | 2001 | USPTO |
| WO2001000030A1 | CNRS | 2001 | WIPO |
| WO2001000147A1 | OREGON STATE (US) | 2001 | WIPO |
| WO2001000337A1 | HOLOGIC INC | 2001 | WIPO |
| WO2001000999A1 | EBARA CORPORATION | 2001 | WIPO |
| WO2001001024A1 | UNIVERSITY OF CALIFORNIA | 2001 | WIPO |
| WO2001001356A1 | CNRS | 2001 | WIPO |
| WO2001001614A1 | CHEMICO INTERNATIONAL INC | 2001 | WIPO |
| WO2001001813A1 | GENECOPOEIA | 2001 | WIPO |
| WO2001002211A1 | UNIVERSITY OF CALIFORNIA | 2001 | WIPO |
| WO2001002300A1 | INSTITUT PASTEUR | 2001 | WIPO |
| WO2001002471A1 | CELLDEX | 2001 | WIPO |
| WO2001002567A1 | MEDIGENE AG (DE) | 2001 | WIPO |
| WO2001002887A1 | AGILENT TECHNOLOGIES | 2001 | WIPO |
| WO2001002900A1 | ACGT PROGENOMICS | 2001 | WIPO |
| WO2001002919A1 | VERTEX PHARMACEUTICALS | 2001 | WIPO |
| WO2001002942A2 | LUDWIG INSTITUTE FOR CANCER RESEARCH | 2001 | WIPO |
| WO2001003494A1 | UNIVERSITY OF CALIFORNIA | 2001 | WIPO |
| WO2001003583A1 | ROCHE DIAGNOSTICS | 2001 | WIPO |
| WO2001003604A2 | BECTON, DICKINSON AND COMPANY | 2001 | WIPO |
| WO2001004447A1 | GOVERNMENT OF CHINA | 2001 | WIPO |
| WO2001004536A1 | BIOSYN ARZNEIMITTEL GMBH (DE) | 2001 | WIPO |
| WO2001005664A2 | PRINCETON UNIVERSITY | 2001 | WIPO |
| WO2001005773A1 | PRINCETON UNIVERSITY | 2001 | WIPO |
| WO2001005971A2 | PHYCOGEN, INC. (US) | 2001 | WIPO |
| WO2001006382A1 | PROKAZYME | 2001 | WIPO |
| WO2001007144A2 | ACTIVE BIOTECH AB | 2001 | WIPO |
| WO2001007150A2 | TAKARA HOLDINGS | 2001 | WIPO |
| WO2001007242A1 | VERTEX PHARMACEUTICALS | 2001 | WIPO |
| WO2001007580A1 | PROMEGA CORPORATION | 2001 | WIPO |
| WO2001007855A1 | DELTAGEN, INC. (US) | 2001 | WIPO |
| WO2001008186A1 | INSTITUT PASTEUR | 2001 | WIPO |
| WO2001008338A2 | THERMO FISHER SCIENTIFIC | 2001 | WIPO |
| WO2001008824A1 | PROLUME LTD | 2001 | WIPO |
| WO2001008829A1 | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US); THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2001 | WIPO |
| WO2001008865A1 | AQUA HEALTH (EUROPE) LIMITED (GB) | 2001 | WIPO |
| WO2001009091A1 | METABOLIX, INC. (US) | 2001 | WIPO |
| WO2001009128A1 | BASF | 2001 | WIPO |
| WO2001009296A1 | BAYER | 2001 | WIPO |
| WO2001009347A2 | AGILENT TECHNOLOGIES | 2001 | WIPO |
| WO2001009348A1 | TAKARA HOLDINGS | 2001 | WIPO |
| WO2001009458A1 | NOVOZYMES | 2001 | WIPO |
| WO2001009464A1 | NOVOZYMES | 2001 | WIPO |
| WO2001009712A1 | AKZO NOBEL N.V. (NL) | 2001 | WIPO |